Isochromophilone III
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Category | Enzyme inhibitors |
Catalog number | BBF-01509 |
CAS | 167173-89-9 |
Molecular Weight | 352.85 |
Molecular Formula | C19H25ClO4 |
Online Inquiry
Capabilities & Facilities
Fermentation Lab
4 R&D and scale-up labs
2 Preparative purification labs
Fermentation Plant
Semi pilot, pilot and industrial plant 4 Manufacturing sites 7 Production lines at pilot scale 100+ Reactors of 30-4000 L; 170+ reactors of 20 KL-30 KL; 24+ reactors of >100 KL 2 Hydrogenation reactors (200 L, 4Mpa and 1000L, 4Mpa)
Product Description
Isochromophilone III is produced by the strain of Pen. multicolor FO-3216 and FO-2328. It inhibited the ACAT of rat hepatocellular microsome and the B-16 melanoma cell with the IC50 (μmol/L) of 110 and 33.
- Specification
- Properties
- Reference Reading
- Price Product List
Synonyms | 6H-2-Benzopyran-6-one, 5-chloro-3-(3,5-dimethyl-1,3-heptadienyl)-1,7,8,8a-tetrahydro-7,8-dihydroxy-7-methyl |
IUPAC Name | (7R,8R,8aR)-5-chloro-3-[(1E,3E,5S)-3,5-dimethylhepta-1,3-dienyl]-7,8-dihydroxy-7-methyl-8,8a-dihydro-1H-isochromen-6-one |
Canonical SMILES | CCC(C)C=C(C)C=CC1=CC2=C(C(=O)C(C(C2CO1)O)(C)O)Cl |
InChI | InChI=1S/C19H25ClO4/c1-5-11(2)8-12(3)6-7-13-9-14-15(10-24-13)17(21)19(4,23)18(22)16(14)20/h6-9,11,15,17,21,23H,5,10H2,1-4H3/b7-6+,12-8+/t11-,15-,17+,19+/m0/s1 |
InChI Key | GJRRBURMULHWIH-WPHCLLNESA-N |
Appearance | Yellow Powder |
Antibiotic Activity Spectrum | neoplastics (Tumor) |
Boiling Point | 489.1°C at 760 mmHg |
Melting Point | 84-85°C |
Density | 1.22 g/cm3 |
BBF-03427 | Tubercidin | Inquiry |
BBF-03753 | Baicalin | Inquiry |
BBF-04727 | Strigolactone GR24 | Inquiry |
BBF-03755 | Actinomycin D | Inquiry |
BBF-05880 | N-Me-L-Ala-maytansinol | Inquiry |
BBF-00693 | Ansamitocin P-3 | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
